Galectin Therapeutics Inc
F:PHPN
Galectin Therapeutics Inc
F:PHPN
Precio:
2,66
EUR
3,91%
Mercado cerrado
Capitalización de mercado:
€165,32 M
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
G
|
Galectin Therapeutics Inc
F:PHPN
|
US |
|
Goldplat PLC
LSE:GDP
|
UK |
|
Figeac Aero SARL
F:1F1
|
FR |
|
N
|
National Fuel Gas Co
F:NFG
|
US |
|
First Phosphate Corp
F:KD0
|
CA |
|
Viasat Inc
LSE:0LPE
|
US |
|
J
|
Japan Steel Works Ltd
F:J9R
|
JP |
|
G
|
Gas Plus SpA
XBER:T9O
|
IT |
|
Emerald Holding Inc
NYSE:EEX
|
US |
Balance general
Desglose del balance general
Galectin Therapeutics Inc
Galectin Therapeutics Inc
El desglose del balance general no está disponible para
Galectin Therapeutics Inc
Galectin Therapeutics Inc
Balance general
Galectin Therapeutics Inc
Galectin Therapeutics Inc
Moneda: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activos | |||||||||||||||||||||||||
| Efectivo y equivalentes de efectivo |
2
|
8
|
11
|
4
|
1
|
1
|
0
|
0
|
6
|
6
|
9
|
10
|
29
|
26
|
15
|
3
|
8
|
47
|
27
|
40
|
19
|
26
|
15
|
18
|
|
| Equivalentes de efectivo |
2
|
8
|
11
|
4
|
1
|
1
|
0
|
0
|
6
|
6
|
9
|
10
|
29
|
26
|
15
|
3
|
8
|
47
|
27
|
40
|
19
|
26
|
15
|
18
|
|
| Inversiones a corto plazo |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cuentas por cobrar totales |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Otros activos corrientes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Activos corrientes totales |
2
|
8
|
11
|
5
|
6
|
1
|
0
|
0
|
6
|
7
|
10
|
11
|
30
|
26
|
16
|
4
|
9
|
48
|
29
|
42
|
21
|
28
|
17
|
19
|
|
| PP&E neto |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E bruto |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciación acumulada |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Activos intangibles |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Otros activos a largo plazo |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Activos totales |
2
N/A
|
8
+251%
|
11
+39%
|
5
-55%
|
6
+28%
|
2
-72%
|
1
-61%
|
0
-37%
|
6
+1.332%
|
7
+5%
|
10
+45%
|
11
+12%
|
30
+177%
|
26
-11%
|
16
-40%
|
4
-74%
|
9
+117%
|
48
+438%
|
30
-39%
|
42
+41%
|
21
-49%
|
28
+32%
|
17
-38%
|
20
+12%
|
|
| Pasivos | |||||||||||||||||||||||||
| Cuentas por pagar |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
2
|
1
|
2
|
4
|
6
|
6
|
3
|
|
| Pasivos acumulados |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
3
|
2
|
2
|
1
|
4
|
7
|
9
|
9
|
8
|
5
|
|
| Deuda a corto plazo |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Porción corriente de la deuda a largo plazo |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
0
|
|
| Otros pasivos corrientes |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Ingresos diferidos |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pasivos corrientes totales |
1
|
0
|
1
|
1
|
6
|
3
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
4
|
3
|
2
|
3
|
5
|
9
|
13
|
16
|
35
|
8
|
|
| Deuda a largo plazo |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
40
|
72
|
85
|
134
|
|
| Otros pasivos |
0
|
0
|
0
|
6
|
0
|
2
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
4
|
|
| Pasivos totales |
1
N/A
|
0
-43%
|
1
+166%
|
7
+625%
|
6
-13%
|
5
-26%
|
1
-75%
|
3
+156%
|
2
-40%
|
2
+25%
|
2
-26%
|
2
+52%
|
2
-32%
|
1
-20%
|
4
+178%
|
3
-21%
|
2
-29%
|
3
+36%
|
5
+89%
|
39
+625%
|
53
+36%
|
88
+65%
|
121
+36%
|
146
+21%
|
|
| Patrimonio | |||||||||||||||||||||||||
| Acciones ordinarias |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
7
|
7
|
7
|
7
|
7
|
8
|
9
|
9
|
9
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Ganancias retenidas |
8
|
13
|
20
|
23
|
26
|
35
|
39
|
48
|
56
|
69
|
80
|
102
|
119
|
140
|
164
|
181
|
196
|
216
|
240
|
271
|
310
|
354
|
402
|
433
|
|
| Capital adicional pagado |
10
|
20
|
30
|
20
|
26
|
32
|
37
|
43
|
54
|
66
|
81
|
103
|
140
|
158
|
167
|
173
|
194
|
260
|
262
|
271
|
275
|
292
|
296
|
304
|
|
| Otro patrimonio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Patrimonio total |
2
N/A
|
8
+370%
|
10
+33%
|
2
N/A
|
0
+99%
|
3
-14.500%
|
0
+84%
|
3
-443%
|
5
N/A
|
4
-3%
|
8
+80%
|
8
+4%
|
28
+240%
|
25
-10%
|
12
-52%
|
1
-90%
|
7
+480%
|
46
+561%
|
24
-47%
|
3
-89%
|
32
N/A
|
60
-87%
|
103
-71%
|
126
-22%
|
|
| Total pasivos y patrimonio |
2
N/A
|
8
+251%
|
11
+39%
|
5
-55%
|
6
+28%
|
2
-72%
|
1
-61%
|
0
-37%
|
6
+1.332%
|
7
+5%
|
10
+45%
|
11
+12%
|
30
+177%
|
26
-11%
|
16
-40%
|
4
-74%
|
9
+117%
|
48
+438%
|
30
-39%
|
42
+41%
|
21
-49%
|
28
+32%
|
17
-38%
|
20
+12%
|
|
| Acciones en circulación | |||||||||||||||||||||||||
| Acciones ordinarias en circulación |
3
|
4
|
5
|
5
|
5
|
7
|
8
|
9
|
11
|
13
|
16
|
18
|
22
|
29
|
33
|
36
|
41
|
57
|
57
|
59
|
59
|
62
|
63
|
65
|
|
| Acciones preferentes en circulación |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
5
|
5
|
5
|
4
|
4
|
4
|
7
|
7
|
7
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Continuar investigando PHPN
Other Galectin Therapeutics Inc listings:
Descubrir más
